Table 4.
Study | Study design | Number of patients | VTE chemoprophylaxis | Method of blood loss calculation | Perioperative blood loss | Conventional or MIS TKA |
---|---|---|---|---|---|---|
Lotke et al. [20] (1991) | Nonblinded RCT | 121 | Aspirin | Formula by maximum Hb decrease | 1518 mL | Conventional |
Hiippala et al. [13] (1995) | Double-blinded RCT | 29 | Enoxaparin | Intraoperative blood loss and postoperative drainage | 1549 mL | Conventional |
Benoni and Fredin [5] (1996) | Double-blinded RCT | 86 | Enoxaparin | Intraoperative blood loss and postoperative drainage | 1410 mL | Conventional |
Keating et al. [17] (1998) | Retrospective study | 280 | Heparin sodium | Formula by maximum Hb decrease | 1925 mL | Conventional |
Good et al. [11] (2003) | Double-blinded RCT | 51 | Dalteparin | Formula by maximum Hb decrease | 1426 mL | Conventional |
Sehat et al. [31] (2004) | Prospective study | 101 | None | Formula by maximum Hb decrease | 1498 mL | Conventional |
Kalairajah et al. [16] (2005) | RCT | 60 | Aspirin | Formula by maximum Hb decrease | 1747 mL | Conventional |
Camarasa et al. [9] (2006) | Double-blinded RCT | 127 | Dalteparin | Formula by maximum Hb decrease | 1784 mL | Conventional |
Current study | Prospective comparative study | 50 | Enoxaparin | Formula by maximum Hb decrease | 1453 mL | MIS |
VTE = venous thromboembolic event; RCT = randomized control trial; TKA = total knee arthroplasty; MIS = minimally invasive surgery; Hb = hemoglobin.